Disparities in Guideline-Concordant Initial Systemic Treatment in Women with HER2-Negative Metastatic Breast Cancer: A SEER-Medicare Analysis
Ami Vyas,1 Meghan Gabriel,2 Sobha Kurian3 1Department of Pharmacy Practice, College of Pharmacy, University of Rhode Island, Kingston, RI, USA; 2Pharmacy Quality Alliance, Alexandria, VA, USA; 3West Virginia University, School of Medicine, Morgantown, WV, USACorrespondence: Ami VyasDepartment of Pha...
Main Authors: | Vyas A, Gabriel M, Kurian S |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2021-04-01
|
Series: | Breast Cancer : Targets and Therapy |
Subjects: | |
Online Access: | https://www.dovepress.com/disparities-in-guideline-concordant-initial-systemic-treatment-in-wome-peer-reviewed-article-BCTT |
Similar Items
-
Residential history in cancer research: Utility of the annual billing ZIP code in the SEER-Medicare database and mobility among older women with breast cancer in the United States
by: S. Namin, et al.
Published: (2021-09-01) -
Connective negation and negative concord in Balto-Slavic
by: Johan van der Auwera, et al.
Published: (2021-07-01) -
A nationwide study on concordance with multimodal treatment guidelines in bipolar disorder
by: Joannes W. Renes, et al.
Published: (2018-10-01) -
Identifying incident oral and pharyngeal cancer cases using Medicare claims
by: Mahnken Jonathan D, et al.
Published: (2013-01-01) -
Guideline-concordant antibiotic therapy is not associated with improved outcomes in healthcare-associated pneumonia
by: Attridge, Russell Thomas
Published: (2010)